Browse > Article

Melanoma in Iran: a Retrospective 10-Year Study  

Ferdosi, Samira (Group of Genetics, Cancer Research Center, Cancer Institute of Iran)
Saffari, Mojtaba (Group of Genetics, Cancer Research Center, Cancer Institute of Iran)
Eskandarieh, Sharareh (Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences (TUMS))
Alishahi, Raziyeh (Group of Genetics, Cancer Research Center, Cancer Institute of Iran)
Moghaddam, Mahsa Ghaffari (Group of Genetics, Cancer Research Center, Cancer Institute of Iran)
Ghanadan, Alireza (Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences (TUMS))
Shirkoohi, Reza (Group of Genetics, Cancer Research Center, Cancer Institute of Iran)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.6, 2016 , pp. 2751-2755 More about this Journal
Abstract
Background: Melanoma, the most life-threatening type of skin cancer, is a malignant tumor initiating in melanocytes that rapidly metastasizes and causes death. Materials and Methods: In this retrospective study, samples were selected from patients' information files in our Cancer Institute in Tehran with a designed checklist. A total of 322 files were found from 2003 until 2012. Then the raw data were transferred to Statistical Package for Social Sciences (SPSS) software version 16 and additional analysis was performed by Students t-test. The important variables were considered according to the available information from history of pathology including age, gender, occupation, stage and location of tumor. Results: Our data showed that incidence of melanoma has been different in the studied 10-year period according to age. Also, incidence of melanoma was higher in men than women. It was more common in lower limbs. More commonly housewives among women and farmers among men were affected by melanoma. Conclusions: Taken together the descriptive data clarified general aspects of this disease for further screening and interventions.
Keywords
Melanoma; risk factors; Iran;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 2014. Cancer Facts. & Figures 2014 [Online]. American Cancer Society. Available: www.cancer.org.
2 Azoury SC, Lange JR (2014). Epidemiology, risk factors, prevention, and early detection of melanoma. Surg Clin North Am, 94, 945-62.   DOI
3 Azzarello LM, Dessureault S, Jacobsen PB (2006). Sunprotective behavior among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev, 15, 142-5.   DOI
4 Bauer J, Buttner P, Murali R, et al (2011). BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res, 24, 345-51.   DOI
5 Lyle M, Long GV (2014). The role of systemic therapies in the management of melanoma brain metastases. Curr Opin Oncol, 26, 222-9.   DOI
6 MacKie RM, Bray C, Vestey J, et al (2007). Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer, 96, 1772-7.   DOI
7 MacKie RM, Bray CA, Hole DJ, et al (2002). Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet, 360, 587-91.   DOI
8 MacKie RM, Hauschild A, Eggermont AM (2009). Epidemiology of invasive cutaneous melanoma. Ann Oncol, 20, 1-7.
9 Malak AT, Yildirim P, Yildiz Z, et al (2011). Effects of training about skin cancer on farmers' knowledge level and attitudes. Asian Pac J Cancer Prev, 12, 117-20.
10 Osterlind A, Hou-Jensen K, Moller Jensen O (1988). Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer, 58, 385-91.   DOI
11 Pukkala E, Aspholm R, Auvinen A, et al (2002). Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ, 325, 567.   DOI
12 Lyon, France: International Agency for Research on Cancer; 2013.
13 Bergman W, Gruis NA (2010). Management of melanoma families. Cancers (Basel), 2, 549-66.   DOI
14 Bishop JN, Harland M, Randerson-Moor J, et al (2007). Management of familial melanoma. Lancet Oncol, 8, 46-54.   DOI
15 Reed KB, Brewer JD, Lohse CM, et al (2012). Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc, 87, 328-34.   DOI
16 Cho E, Rosner BA, Colditz GA (2005). Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev, 14, 1241-4.   DOI
17 Elwood JM, Gallagher RP (1998). Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer, 78, 276-80.   DOI
18 Erdei E, Torres SM (2010). A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther, 10, 1811-23.   DOI
19 Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. 2012. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Online].
20 Gajda M, Kaminska-Winciorek G (2014). Do not let to be late:overview of reasons for melanoma delayed diagnosis. Asian Pac J Cancer Prev, 15, 3873-7.   DOI
21 Garbe C, Terheyden P, Keilholz U, et al (2008). Treatment of melanoma. Dtsch Arztebl Int, 105, 845-51.
22 Saridi MI, Rekleiti MD, Toska AG, et al (2014). Assessing a sun protection program aimed at Greek elementary school students for malign melanoma prevention. Asian Pac J Cancer Prev, 15, 5009-18.   DOI
23 Roh MR, Eliades P, Gupta S, et al (2015). Cutaneous Melanoma in Women. Int J Womens Dermatol, 1, 21-5.   DOI
24 Sanlorenzo M, Vujic I, Posch C, et al (2015a). The Risk of Melanoma in Pilots and Cabin Crew: UV Measurements in Flying Airplanes. JAMA Dermatol, 151, 450-2.   DOI
25 Sanlorenzo M, Wehner MR, Linos E, et al (2015b). The risk of melanoma in airline pilots and cabin crew: a meta-analysis. JAMA Dermatol, 151, 51-8.   DOI
26 Siegel R, DeSantis C, Virgo K, et al (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 62, 220-41.   DOI
27 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI
28 Swerdlow AJ, English J, MacKie RM, et al (1986). Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed), 292, 1555-9.   DOI
29 Swerdlow AJ, English JS, MacKie RM, et al (1988). Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ, 297, 647-50.   DOI
30 Tsao H, Atkins MB, Sober AJ (2004). Management of cutaneous melanoma. N Engl J Med, 351, 998-1012.   DOI
31 Uysal-Sonmez O, Tanriverdi O, Esbah O, et al (2013). Multicenter evaluation of patients with cutaneous malignant melanoma in Turkey: MELAS study. Asian Pac J Cancer Prev, 14, 533-7.   DOI
32 Karagas MR, Zens MS, Stukel TA, et al (2006). Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control, 17, 11-9.   DOI
33 Green A, McCredie M, Giles G, et al (1996). Occurrence of melanomas on the upper and lower limbs in eastern Australia. Melanoma Res, 6, 387-94.   DOI
34 Houghton AN, Polsky D (2002). Focus on melanoma. Cancer Cell, 2, 275-8.   DOI
35 Joosse A, de Vries E, Eckel R, et al (2011). Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol, 131, 719-26.   DOI
36 Li WQ, Han J, Widlund HR, et al (2014). CXCR4 pathway associated with family history of melanoma. Cancer Causes Control, 25, 125-32.   DOI
37 Long GV, Menzies AM, Nagrial AM, et al (2011). Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol, 29, 1239-46.   DOI
38 Liebner DA, Walston SA, Cavaliere R, et al (2014). Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib. Melanoma Res, 24, 172-6.   DOI
39 Lobos-Gonzalez L, Aguilar-Guzman L, Fernandez JG, et al (2014). Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models. Melanoma Res, 24, 108-19.   DOI